-
Dr. Rong Fu: Dedicated Exploration – New Insights and Treatments in Aplastic Anemia
Aplastic Anemia (AA), a type of bone marrow failure syndrome, is challenging to treat. While hematopoietic stem cell transplantation (HSCT) may offer a cure, it is hindered by donor availability and high risk. Medical treatments provide symptom relief but with limited efficacy and potential for relapse. At the recent 18th Annual Chinese Society of Hematology…
-
Professor Eolia Brissot: The Deepening and Expansion of Blinatumomab in Non-Chemotherapy Strategies for Acute Lymphoblastic Leukemia
The 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association attracted hundreds of domestic and international authoritative experts and scholars in the field of hematology to gather together. During the conference, “Hematology Frontier” specially invited Professor Eolia Brissot from Hôpital Saint-Antoine in Paris to share the latest explorations of non-chemotherapy strategies in the…
-
Professor Owen O’Connor and Professor Zhengzi Qian Review the Current Status and Latest Advances in the Treatment of R/R PTCL
The 5th Tianjin International Lymphoma Academic Conference, as an academic platform to promote international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and cooperation in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Professor Owen O’Connor, President of the Lymphoma Alliance and from the…
-
CSCO 2024 | Dr. Rongbo Lin: POF & POFI Regimens May Set New First-Line Standard for Advanced Gastric Cancer
From September 25 to 29, 2024, the highly anticipated 27th Chinese Clinical Oncology Annual Conference and CSCO Annual Meeting took place in Xiamen. Dr. Rongbo Lin of Fujian Cancer Hospital shared key findings from his team’s research in gastric cancer. During the conference, Oncology Frontier conducted an in-depth interview with Professor Lin, discussing the clinical…
-
ASCO GI | Dr. Pashtoon M. Kasi: ctDNA Proven to Guide Adjuvant Chemotherapy in Colorectal Cancer
Despite ctDNA’s nascent role in treatment decision-making, it is a proven marker of MRD in CRC patients, and research increasingly explores its role in guiding treatment across gastrointestinal cancers. At the 2024 ASCO Gastrointestinal Cancers Symposium, Dr. Pashtoon M. Kasi from Weill Cornell Medicine and Dr. Jeanne Tie from the Peter MacCallum Cancer Centre presented…
-
ASCO 2024 | Dr. John Sweetenham: Application of AI Patient Navigation Tool in Colorectal Cancer Screening
At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Alyson B. Moadel from the Albert Einstein Montefiore Medical Center unveiled a study on artificial intelligence (AI). The findings demonstrated that an AI-based patient navigation tool effectively assisted patients who missed initial colonoscopy appointments, significantly increasing screening completion rates. Recently, Dr. John Sweetenham…
-
ASCO 2024 | Dr. Shaalan Beg: Breakthrough Study on Thermal Ablation for Small Colorectal Liver Metastases
At the 2024 ASCO Annual Meeting, a groundbreaking study led by Dr. Martijn Ruben Meijerink from Amsterdam University Medical Center focused on thermal ablation versus surgery for small colorectal liver metastases. This study has the potential to change clinical practice. Dr. Shaalan Beg from the Simmons Comprehensive Cancer Center at the University of Texas Southwestern…
-
Dr. Norbert Claude Gorin: Autologous Transplant Combined with Immunotherapy, Expected to Optimize the Treatment Landscape of AML
Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, “Hematology Frontier” specially invited Dr. Norbert Claude Gorin from Hôpital Saint-Antoine in Paris, a member of the French National…
Connecting Medical Expertise through Media